Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases
The Pharma Data
NOVEMBER 15, 2020
” “We are committed to advancing innovative science and transformative medicines for people affected by different immune mediated diseases”, says James Sabry , Global Head, Roche Pharma Partnering. ” About Immune Mediated Diseases. A wide range of human diseases is driven by deregulated immune function.
52 
Let's personalize your content